Biologics Treatment Limits Disease Activity and Bone Metabolism in Patients with Rheumatoid Arthritis

Próchnicka RK^1,2, Gorycka PA^3*, Mańczak M⁴, Giemza FA², Wojciechowska M⁵, Wojdasiewicz P^1,6, Maśliński S¹, Olesińska M² and Szukiewicz D¹

¹Department of General and Experimental Pathology, Warsaw Medical University, Poland

²Department and Polyclinic of Systemic Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

³Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

⁴Department of Epidemiology and Health Promotion, National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

⁵Central Clinical Laboratory, National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

⁶Departament of Rheumoorthopedic Surgery, National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

^*Corresponding Author: Gorycka PA, Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warszawa, Poland, Tel: +48 22 844-57-26 Email: